parkinsonsnewstoday.com/new...
Researchers have identified distinct changes to introns — an historically understudied component of genes — associated with the presence and progression of Parkinson’s disease.
Learning more about these changes and the signaling pathways they impact may help in identifying biomarkers and treatment targets for the neurodegenerative disease, the researchers said.
“This work opens a new avenue of genomic research towards developing novel approaches for improved diagnosis and more targeted therapeutic intervention in Parkinson’s disease progression,” Sulev Koks, MD, PhD, a professor at the Perron Institute for Neurological and Translational Science and Murdoch University, both in Australia, and the study’s first author, said in a press release.
---------------------------------------
STAY STRONG!
A 'MIRACLE CURE' is just around the corner!
Parkinson's Disease: emerging treatment target, the NLRP inflammasome. 
